Arch Therapeutics, Inc. (ARTH)
USD 0.23
(31.81%)
USD 0.23
(31.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.37 Million | -4.45 Million | -5.95 Million | -5.04 Million | -5.26 Million | -5.91 Million |
| Net Income | -6.98 Million | -5.27 Million | -6.24 Million | -4.69 Million | -4.54 Million | -4.81 Million |
| Depreciation & Amortization | 1966.00 | 3196.00 | 2587.00 | 6926.00 | 8238.00 | 5342.00 |
| Deferred income taxes | 773.06 Thousand | - | - | - | -1.82 Million | - |
| Stock-based compensation | 249.55 Thousand | 499.58 Thousand | 496.06 Thousand | 898.29 Thousand | 1.18 Million | 1.74 Million |
| Change in working capital | 2.2 Million | 766.87 Thousand | -111.61 Thousand | -639.71 Thousand | -132.13 Thousand | -211.59 Thousand |
| Other non-cash items | 379.59 Thousand | -449.87 Thousand | -105.18 Thousand | -618.88 Thousand | 43 Thousand | -2.63 Million |
| Investing Cash Flow | -4521.00 | - | -3275.00 | -2455.00 | - | -15.41 Thousand |
| Investments in PPE | -4521.00 | - | -3275.00 | -2455.00 | - | -15.41 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.85 Million | 2.93 Million | 7.26 Million | 3.82 Million | 2.78 Million | 4.6 Million |
| Debt repayment | -644.67 Thousand | -482.36 Thousand | -1.05 Million | -726.3 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.2 Million | 8959.00 | 6.21 Million | 2.16 Million | 2.74 Million | 4.46 Million |
| Other Financing Activities | 1.28 Million | 3.4 Million | 2.1 Million | 2.38 Million | 32.4 Thousand | 141.08 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 976.2 Thousand | 846.86 Thousand | 66.03 Thousand | -191.5 Thousand | 372.6 Thousand | -103.93 Thousand |
| Inventory | 50.34 Thousand | -569.15 Thousand | -307.76 Thousand | -681.73 Thousand | -346.64 Thousand | - |
| Other working capital | 1.17 Million | 489.16 Thousand | 130.11 Thousand | 233.52 Thousand | -158.09 Thousand | -107.66 Thousand |
| Cash at beginning of period | 746.94 Thousand | 2.26 Million | 959.3 Thousand | 2.18 Million | 4.66 Million | 5.99 Million |
| Cash at end of period | 222.72 Thousand | 746.94 Thousand | 2.26 Million | 959.3 Thousand | 2.18 Million | 4.66 Million |
| Capital Expenditure | -4521.00 | - | -3275.00 | -2455.00 | - | -15.41 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -524.22 Thousand | -1.51 Million | 1.3 Million | -1.22 Million | -2.48 Million | -1.32 Million |
| Free Cash Flow | -3.37 Million | -4.45 Million | -5.96 Million | -5.04 Million | -5.26 Million | -5.92 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.65 Million | -1.46 Million | -2.68 Million | -6.98 Million | -2.45 Million | -1.82 Million |
| Depreciation & Amortization | 376.00 | 559.00 | 650.00 | 1966.00 | 650.00 | 273.00 |
| Deferred income taxes | - | - | 1.79 Million | 773.06 Thousand | -185.56 Thousand | - |
| Stock-based compensation | 10.32 Thousand | -3091.00 | 25.9 Thousand | 249.55 Thousand | 35.74 Thousand | 41.25 Thousand |
| Change in working capital | 356.06 Thousand | 346.4 Thousand | 776.92 Thousand | 2.2 Million | 363.32 Thousand | 250.05 Thousand |
| Other non-cash items | 4.43 Million | 219.78 Thousand | -776.92 Thousand | 379.59 Thousand | 1.01 Million | 633.97 Thousand |
| Investing Cash Flow | - | - | - | -4521.00 | -4521.00 | - |
| Investments in PPE | 1.00 | - | - | -4521.00 | -4521.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 915.24 Thousand | 520.73 Thousand | 845.73 Thousand | 2.85 Million | 1.36 Million | 954.59 Thousand |
| Debt repayment | -915.24 Thousand | -520.73 Thousand | -104.26 Thousand | -644.67 Thousand | -385.61 Thousand | -35.41 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 2.2 Million | 2.2 Million | - |
| Other Financing Activities | 915.24 Thousand | 520.73 Thousand | 950 Thousand | 1.28 Million | -456.79 Thousand | 990.01 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -52.86 Thousand | 197.09 Thousand | 468.21 Thousand | 976.2 Thousand | -166.95 Thousand | 45.26 Thousand |
| Inventory | 9317.00 | 6256.00 | 28.65 Thousand | 50.34 Thousand | 18.43 Thousand | 19.44 Thousand |
| Other working capital | 399.61 Thousand | 143.04 Thousand | 280.04 Thousand | 1.17 Million | 511.84 Thousand | 185.33 Thousand |
| Cash at beginning of period | 26.42 Thousand | 205.85 Thousand | 222.72 Thousand | 746.94 Thousand | 86.54 Thousand | 29.49 Thousand |
| Cash at end of period | 30.03 Thousand | 26.42 Thousand | 205.85 Thousand | 222.72 Thousand | 222.72 Thousand | 86.54 Thousand |
| Capital Expenditure | 1.00 | - | - | -4521.00 | -4521.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3604.00 | -179.42 Thousand | -16.87 Thousand | -524.22 Thousand | 136.17 Thousand | 57.04 Thousand |
| Free Cash Flow | -911.64 Thousand | -700.15 Thousand | -862.6 Thousand | -3.37 Million | -1.23 Million | -897.54 Thousand |
DDOG
CXB
NACLIND
THOMASCOOK
BNNNF
2380